Literature DB >> 18293908

Synthesis, cannabinoid receptor affinity, and molecular modeling studies of substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides.

Romano Silvestri1, Maria Grazia Cascio, Giuseppe La Regina, Francesco Piscitelli, Antonio Lavecchia, Antonella Brizzi, Serena Pasquini, Maurizio Botta, Ettore Novellino, Vincenzo Di Marzo, Federico Corelli.   

Abstract

The new 1-phenyl-5-(1 H-pyrrol-1-yl)pyrazole-3-carboxamides were compared with the reference compounds AM251 and SR144528 for cannabinoid hCB 1 and hCB 2 receptor affinity. Compounds bearing 2,4-dichlorophenyl or 2,4-difluorophenyl groups at position 1 and 2,5-dimethylpyrrole moiety at position 5 of the pyrazole nucleus were generally more selective for hCB 1. On the other hand, the N-cyclohexyl group at the 3-carboxamide was the determinant for the hCB 2 selectivity, in particular when a 3,4-dichlorophenyl group was also present at position 1. Compound 26 was the most selective ligand for the hCB 1 receptor ( K i (CB 2)/ K i (CB 1) = 140.7). Derivative 30, the most potent hCB 1 ligand ( K i = 5.6 nM), was equipotent to AM251 and behaved as an inverse agonist in the cAMP assay (EC 50 approximately 1 nM). The carbonyl oxygen of both 26 and 30 formed a H-bond with K3.28(192), while the substituents at the nitrogen fitted in a pocket formed by lipophilic residues. This H-bonding interaction was proposed to account for the high affinity for receptors' inactive state and the inverse agonist activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18293908     DOI: 10.1021/jm070566z

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  15 in total

1.  Tonic regulation of GABAergic synaptic activity on vasopressin neurones by cannabinoids.

Authors:  L Wang; W E Armstrong
Journal:  J Neuroendocrinol       Date:  2012-04       Impact factor: 3.627

2.  Establishment of recombinant cannabinoid receptor assays and characterization of several natural and synthetic ligands.

Authors:  Sarah Geiger; Kathrin Nickl; Erich H Schneider; Roland Seifert; Jörg Heilmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-07-09       Impact factor: 3.000

3.  Probing the interaction of SR141716A with the CB1 receptor.

Authors:  Joong-Youn Shim; Alexander C Bertalovitz; Debra A Kendall
Journal:  J Biol Chem       Date:  2012-09-20       Impact factor: 5.157

4.  Screen of Unfocused Libraries Identified Compounds with Direct or Synergistic Antibacterial Activity.

Authors:  Claudia Mugnaini; Filomena Sannio; Antonella Brizzi; Rosita Del Prete; Tiziana Simone; Teresa Ferraro; Filomena De Luca; Federico Corelli; Jean-Denis Docquier
Journal:  ACS Med Chem Lett       Date:  2020-03-06       Impact factor: 4.345

5.  Development and characterization of immobilized cannabinoid receptor (CB1/CB2) open tubular column for on-line screening.

Authors:  R Moaddel; A Rosenberg; K Spelman; J Frazier; C Frazier; S Nocerino; A Brizzi; C Mugnaini; I W Wainer
Journal:  Anal Biochem       Date:  2011-01-06       Impact factor: 3.365

6.  Structural Basis of Species-Dependent Differential Affinity of 6-Alkoxy-5-Aryl-3-Pyridinecarboxamide Cannabinoid-1 Receptor Antagonists.

Authors:  Malliga R Iyer; Resat Cinar; Jie Liu; Grzegorz Godlewski; Gergö Szanda; Henry Puhl; Stephen R Ikeda; Jeffrey Deschamps; Yong-Sok Lee; Peter J Steinbach; George Kunos
Journal:  Mol Pharmacol       Date:  2015-05-26       Impact factor: 4.436

7.  CB1 receptors mediate the analgesic effects of cannabinoids on colorectal distension-induced visceral pain in rodents.

Authors:  Mikael Brusberg; Susanne Arvidsson; Daiwu Kang; Håkan Larsson; Erik Lindström; Vicente Martinez
Journal:  J Neurosci       Date:  2009-02-04       Impact factor: 6.167

8.  Design, Synthesis, and Antitumor Evaluation of Novel Pyrazolo[3,4-d]pyrimidine Derivatives.

Authors:  Manal M Kandeel; Lamia W Mohamed; Mohammed K Abd El Hamid; Ahmed T Negmeldin
Journal:  Sci Pharm       Date:  2012-06-25

9.  A new synthetic approach for pyrazolo[1,5-a]pyrazine-4(5H)-one derivatives and their antiproliferative effects on lung adenocarcinoma cell line.

Authors:  Meltem Tan Uygun; Karina Amudi; İrem Doğan Turaçlı; Nurettin Menges
Journal:  Mol Divers       Date:  2021-01-02       Impact factor: 2.943

10.  Computational Prediction and Biochemical Analyses of New Inverse Agonists for the CB1 Receptor.

Authors:  Caitlin E Scott; Kwang H Ahn; Steven T Graf; William A Goddard; Debra A Kendall; Ravinder Abrol
Journal:  J Chem Inf Model       Date:  2016-01-05       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.